Growth Factors & Biomimetic Peptides
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
90
NCT07204639
Safety and Efficacy of RAP-103 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 1, 2025
Completion: Dec 30, 2025
Loading map...